Drug Pipeline

Posaconazole Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
5
Active Studies
4
Recruiting
1
Phase 3
5
Top Sponsors
Active Studies by Phase
Phase 3
1
Phase 2
2
Phase 1/2
2
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07261150 Histoplasmosis Induction and Consolidation Therapy Factorial Randomized Clinical Trial… Histoplasmosis Not Yet Recruiting
Phase 2
NCT06541067 Study of Posaconazole Prophylaxis in Patients Receiving Hematopoietic Stem Cell Allograft… Hematologic Malignancy Recruiting
NCT06802757 Posaconazole Plus PD-1 Inhibitors and Chemotherapy vs PD-1 Inhibitors and Chemotherapy in… Breast Cancer Recruiting
Phase 1/2
NCT04771130 A Study of BGB-11417 in Participants With Myeloid Malignancies Acute Myeloid Leukemia Recruiting
NCT07155226 Study of AZD3632 Monotherapy or in Combination With Anticancer Agents in Participants… Acute Lymphoblastic Leukaemia Recruiting
Sponsors Running Posaconazole Trials
BeiGene (1) Nantes University Hospital (1) Shandong Cancer Hospital and Institute (1) AstraZeneca (1) University of Minnesota (1)
Disease Areas
Leukemia (2) Acute Myeloid Leukemia (AML) (2) Myelodysplastic Syndromes (MDS) (2) Myelofibrosis (1) Breast Cancer (1)
Get alerts when Posaconazole trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free